الفهرس | Only 14 pages are availabe for public view |
Abstract Ventricular septal defect (VSD) is the most common (approximately 20%) of congenital heart disease. Patients with a volume overload of the left chamber due to a PM VSD require closure of the defect to prevent ventricular dilatation, dysfunction, arrhythmias, aortic regurgitation, pulmonary arterial hypertension, endocarditis, and double-chambered right ventricle. The standard treatment of PM VSD is open surgery, which is widely performed with minimal operative mortality. However, there are still the risks of complete atrioventricular block (cAVB), residual shunt, post pericardiotomy syndrome, wound infection, etc. Given its efficacy, minimal trauma, and rapid post surgery recovery, transcatheter interventional therapy for VSD can be an alternative to surgical closure with acceptable mortality and morbidity, with encouraging results. |